ArticleNigerian medical journal : journal of the Nigeria Medical Association
Microbial Milieu and Antibiogram of Female Genital Infections in a Tertiary Health Facility in Nigeria.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaginal infections constitute a significant health challenge for women and lead to long-term complications if not promptly and adequately treated. We aimed to determine the prevalent organisms in vaginal infections in our women and the antibiotic susceptibility of the offending organisms. Methodology: This was a prospective cross-sectional study of 635 consecutive women attending the Obstetrics and Gynaecology clinic of the University of Port Harcourt Teaching Hospital from 1 Results: Four hundred and eight (64.3%) of the women were gynaecological patients, while the remaining 227 (35.7%) were obstetric patients. One hundred and ninety-one(30.1%) out of the total 635 study population did not have any growth of the organisms tested for in the culture assay, while the remaining 444 (69.9%) had. One hundred and forty-four of the women(22.2%) had growth of candida Albicans, 130 (20.5%) had staphylococcus aureus, 78 (12.3%) - Klebsiella species (spp), 48 (7.6%) - Escherichia coli, 30 (4.7%) - Pseudomonas species, 8 (1.3%) - Proteus species and 6 (0.9%) of the women had Streptococcus species. The commonest pathogen involved in vaginal infections in women was Candida albicans. The commonest bacterial isolate was Staphylococcus aureus and then Klebsiella species. The bacteria were susceptible to Ceftriaxone, Cefpodoxime, Cefotaxime, Cefixime, Ciprofloxacin, Dorepenem and Ampicillin. They were mainly resistant to cefuroxime, ceftazidime, Augmentin, Erythromycin and Meropenem. Conclusion: Candida albicans is prevalent in our women. Staphyloccocus aureus is the commonest bacterial organism in women with vaginal infections. Empirical antibiotic treatment using Cetriazone, Cefpodoxime and Ciprofloxacin, available in our setting, may be beneficial while awaiting the culture results in women with suspected vaginal infections.
Indexed as
Identifiers
38867752PMC11165321What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.